MedTech Featured Stories

Bristol subpoenaed over foreign sales practices

4/26/2012

U.S. drugmaker Bristol-Myers Squibb Co said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries.

Bristol-Myers, in a filing, said it received the subpoena from the U.S. Securities and Exchange Commission (SEC) last month in connection with an investigation under the Foreign Corrupt Practices Act (FCPA).
 

Reuters



Return to Previous Page

Today Is:
Saturday, July 26, 2014


July Events

<< >>
SMTWTFS
12345
6789101112
13141516171819
20212223242526
2728293031